Shan-liang M. Zhong - Publications

A prognostic risk model construction for endometrial cancer based on inflammation-related genes.

Journal: Yi chuan = Hereditas

Published: September 17, 2025

Applications of single-cell transcriptomics: updated insights in endometrial cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 13, 2025

tRF-22-WE8SPOX52 promotes progression of breast cancer by down-regulating MAP2K4.

Journal: Medical oncology (Northwood, London, England)

Published: March 27, 2025

Identification of a novel tRNA-derived small RNA fragment, tRF-16-2YU04DE, with the potential of inhibiting endometrial cancer progression.

Journal: Medical oncology (Northwood, London, England)

Published: January 17, 2025

Androgen receptor expression and clinical characteristics in breast cancer.

Journal: World journal of surgical oncology

Published: April 29, 2024

Circular RNA HSDL2 promotes breast cancer progression via miR-7978 ZNF704 axis and regulating hippo signaling pathway.

Journal: Breast cancer research : BCR

Published: February 05, 2024

CircABHD2 Inhibits Malignant Progression of Endometrial Cancer by Regulating NAD+/NAMPT Metabolism Axis.

Journal: Molecular biotechnology

Published: September 05, 2023

Single-cell RNA-seq reveals MIF-(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.

Journal: Oral oncology

Published: September 01, 2023

circNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis.

Journal: European journal of pharmacology

Published: August 31, 2023

Circulating exosomal miRNAs and cancer early diagnosis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 14, 2021

Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.

Journal: Cell death & disease

Published: November 25, 2020

The role of long non-coding RNAs in drug resistance of cancer.

Journal: Clinical genetics

Published: February 15, 2020